For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Products
Food Fights: When Puffery Crosses the Line
As technological and institutional innovations have made it possible to replace the problems of starvation with those of obesity, we’ve begun to take for granted…
Products
The Origins of “Biotechnology”
Full Document Available in PDF Excerpted from Chapter 1 of The Frankenfood…
Washington Post
After Criticism, FDA Will Strengthen Drug Safety Checks
Washington Post
After Criticism, FDA Will Strengthen Drug Safety Checks
New York Times
FDA’s Drug Safety System Will Get Outside Review
Op-Eds
Demonize – Then Pulverize
Ten years ago last May, a new type of lawsuit was filed against the tobacco industry. That industry was no stranger to lawsuits; since the…